MODERATE a due to risk of bias The mean quality of life - KCCQ at 12 months in the control groups was The mean quality of life - KCCQ at 12 months in the intervention groups was Quality of life - SF-12 (Physical component) MODERATEa due to risk of bias The mean quality of life SF-12 (physical component) at 12 months in the control groups was The mean quality of life SF-12 (physical component) at 12 months in the intervention groups was Treating Heart Failure Chronic Heart Failure NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: Outcomes No of Participants (studies) Follow up Quality of the evidence (GRADE) Relativ e effect CI) Anticipated absolute effects Risk with medical therapy Risk difference with CABG (95% CI) Quality of life - SF-12 (Mental Component) MODERATEa due to risk of bias The mean quality of life SF-12(mental component) at 12 months in the control groups was The mean quality of life SF-12 (mental component) at 12 months in the intervention groups was All-cause hospitalisations 1212 MODERATEb due to imprecision (from 34 fewer to 141 fewer) Subsequent procedures - CABG 1212 MODERATEa due to risk of bias Peto Odds Ratio (from 138 fewer to 153 fewer) Subsequent procedures - PCI 1212 LOWa,b due to risk of bias, imprecision (from 35 fewer to 8 more) NYHA class I 1212 LOWb,c due to imprecision, indirectness (from 21 more to 140 more) LOWa,b due to risk of (from 16 fewer to 47 more) Treating Heart Failure Chronic Heart Failure NICE 2018. All rights reserved. Subject to Notice of rights. 